| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |